Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN vs NALDEMEDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN vs NALDEMEDINE: Safety Overview

Metric NAFCILLIN NALDEMEDINE
Total FAERS Reports 215 677
Deaths Reported 18 167
Death Rate 8.4% 24.7%
Hospitalizations 98 105
Average Patient Age 50.7 yrs 66.5 yrs
% Female Patients 50.5% 54.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Mar 23, 2017
Manufacturer Eugia US LLC BioDelivery Sciences International Inc
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription